Acadia Pharmaceuticals | 销售和管理费用

Selling And Administration Expenses 更改 日
Acadia Pharmaceuticals USD 107.99M 3.47M 2024-03
ALKERMES USD 179.75M 9.96M 2024-03
Alnylam Pharmaceuticals USD 210.8M 12.67M 2024-03
Biogen USD 581.5M 27M 2024-03
BioMarin Pharmaceutical USD 225.91M 49.12M 2024-03
Bristol-Myers Squibb USD 2.37B 303M 2024-03
Corcept Therapeutics USD 56.27M 9.12M 2024-03
Cytokinetics USD 45.5M 1.39M 2024-03
Eisai JPY 92.17B 616M 2023-12
Eli Lilly USD 1.84B 88.5M 2024-03
Incyte USD 300.3M 6.44M 2024-03
Intra Cellular Therapies USD 113.08M 8.36M 2024-03
J&J USD 5.06B 753M 2024-03
Moderna USD 274M 196M 2024-03
Neurocrine Biosciences USD 243.1M 38.9M 2024-03
Pfizer USD 3.5B 976M 2024-03
Prothena USD 17.46M 524K 2024-03
PTC Therapeutics USD 73.27M 3.02M 2024-03
Sarepta Therapeutics USD 127M 6.11M 2024-03
Ultragenyx Pharmaceutical USD 78.16M 1.33M 2024-03
Vertex Pharmaceuticals USD 342.7M 78.9M 2024-03



Acadia Pharmaceuticals 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.